Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.
Registrars:
Key Personnel
COO:
Timothy J Mitchell
Non-Executive Director:
Michael Owen, Clive Birch
Executive Director:
John C Reader
Non-Executive Chairman:
Stephen Parker
Contact Details
Address:
Unit 2A, Langford Arch,London Road, Pampisford, Cambridge, Cambridgeshire, United Kingdom